ImmunityBio, Inc. ( IBRX) - Key Metrics
IBRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.05 | -$0.22 | -$0.14 | -$0.14 |
| 2026Q1 | $0.04 | -$0.62 | -$0.07 | -$0.08 |
| 2025Q4 | $0.04 | -$0.06 | -$0.07 | -$0.07 |
| 2025Q3 | $0.03 | -$0.07 | -$0.07 | -$0.07 |
| 2025Q2 | $0.03 | -$0.10 | -$0.09 | -$0.09 |
IBRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.95 |
| 2026Q1 | 0% | -3.09 |
| 2025Q4 | 0% | -7.91 |
| 2025Q3 | 0% | -8.66 |
| 2025Q2 | 0% | -6.60 |
IBRX
Price: $7.95
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.95 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Market Capitalization: 8.1 billion